Specific Responsibilities of the JRC. Until the expiration of the Research Term, the JRC shall review and oversee the performance of the Research Plans. In particular, the JRC shall:

Specific Responsibilities of the China Committee. In addition to its general responsibilities, the China Committee shall have the following responsibilities in particular for the Territory, certain of which shall be subject to approval by the JSC:

Responsibilities. The JSC’s responsibilities shall include, but not be limited to, the following functions:

Specific Responsibilities of the Parties. Each Party shall use Commercially Reasonable Efforts to conduct and shall be responsible for activities assigned to it by the applicable Protocols and/or the JDC that such Party is not otherwise obligated to perform by this Agreement, provided that, except as set forth in this Agreement, in no event shall either Party be obligated to perform any such assigned activities without its prior written consent (which may be reflected in the minutes of meetings of the JDC or in a Protocol). As of [[Nektar:Organization]], each Party shall be responsible for the following activities:

Specific Responsibilities of the Parties. Subject to the terms of this Agreement, each Party shall use Commercially Reasonable Efforts to # supply the quantities of its Compound as needed to conduct a Combined Therapy Trial on a timely basis, with BioXcel packaging, labeling and delivering same to study sites, in accordance with the time frame(s) established by the JDC; # to conduct and complete each Combined Therapy Trial and any Statistical Analysis Plans and Bioanalysis Plans relating thereto on a timely basis in accordance with the Protocol, Bioanalysis Plans, Statistical Analysis Plans and Third Party agreements relating thereto, and # to timely provide Rights of Cross-Reference where required by this Agreement. Each Party shall be responsible for activities assigned to it by the Protocol and/or JDC that such Party is not otherwise obligated to perform by this Agreement, provided that, except as set forth in this Agreement, in no event shall either Party be obligated to perform any such assigned activities without its prior written consent (which may be reflected in the minutes of meetings of the JDC or in the Protocol). As of the Effective Date, each Party shall be responsible for the following activities:

Specific Responsibilities of the JPC. In addition to its general responsibility of providing a forum for the discussion of intellectual property matters contemplated by this Article 14, the JPC shall in particular be responsible for: # making initial determinations of inventorship in accordance with the terms of Section 14.1; # discussing (but not approving) overall strategies for the Prosecution and Maintenance and enforcement of the Stoke Patents, Acadia Patents and Joint Collaboration Patents that are not [[Unknown Identifier]] Product Patents; and # with respect to any [[Unknown Identifier]] Product Patents for which the Parties are jointly controlling Prosecution and Maintenance, # selecting lead patent counsel, # discussing and determining strategies for the Prosecution and Maintenance and enforcement of the [[Unknown Identifier]] Product Patents, # reviewing and commenting on substantive filings and documents related to the Prosecution and Maintenance of the such [[Unknown Identifier]] Product Patents, and # instructing lead patent counsel with respect to Prosecution and Maintenance of such [[Unknown Identifier]] Product Patents. The JPC shall endeavor to make decisions by consensus, with the representatives of each Party having, collectively, one (1) vote on behalf of that Party. If the JPC is unable to reach consensus on any decision before it, then the matter shall be escalated to the JSC, and if the JSC is unable to reach consensus on any decision before it, then such decision will be resolved in accordance with Section 3.7(a).

The responsibilities of the JOC will be to:

The responsibilities of the JMC will be to:

Specific Responsibilities of the Recipient. The Recipient shall, subject to the terms of the Protocol, applicable terms and conditions of this Agreement, and any other agreement between the Parties relating to the Combined Therapy Clinical Trial, manage and be responsible for the conduct of the Combined Therapy Clinical Trial, including timelines and contingency planning. In particular, and not in limitation of the foregoing, the Recipient shall perform (itself and/or through Third Parties, including clinical trial sites, CROs and investigators) and/or be responsible for the following (items # to # below), collectively the “Operational Matters”) with respect to the Combined Therapy Clinical Trial:

Responsibilities. The CPC shall: